Press Releases

Termeer was a key architect in the founding of BIO, a mentor to countless entrepreneurs, executives and researchers, and passionate in his pursuit of innovative patient-centric drug development. Washington, DC (May 15, 2017) – Henri…

Washington, D.C. (May 12, 2017) – The Biotechnology Innovation Organization (BIO) issued the following statement regarding initial results of the 100-Day Action Plan of the U.S.-China Comprehensive Economic Dialogue:

Bio-based Technologies Address Human, Animal, Plant and Environmental Health Washington, D.C. (May 11, 2017) – At its heart, the concept of One Health is rooted in the notion that the health of humans, animals, and the environment are all…

Former First Lady of Massachusetts and New York Times best-selling author will speak about the power of resilience in overcoming obstacles, advocating for families and spearheading brain health research

Washington, DC (May 9, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the confirmation of Dr. Scott Gottlieb as Commissioner of the Food and Drug Administration (FDA):

BIO today thanked Sen. Ron Wyden (D-OR) and 21 Senate co-sponsors for proposing a technology neutral tax credit for domestic production of clean transportation fuel. Sen. Wyden’s Clean Energy for America Act proposes a set of long-term energy tax…

Washington, DC (May 4, 2017) – Today, the Biotechnology Innovation Organization (BIO) thanks Reps. Pat Meehan (R-PA), Richard Neal (D-MA), Mike Kelly (R-PA), Ron Kind (D-WI), and John Larson (D-CT) for introducing the Partnerships to Advance…

SBIR-funded companies will showcase biotechnology breakthroughs at BIO 2017 International Convention 

Global Adoption of Biotech Crops Reaches New Peak of 457 Million AcresWashington, D.C. (May 4, 2017) – Millions of farmers around the world continue to choose genetically modified (GM) crop varieties because of their environmental and socio-economic…

Washington, DC (May 3, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding today’s prescription drug spending report from Blue Cross Blue Shield: “Today’s report from…